Aclaris Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $92.5M | $9.9M |
| FY2016 | — | $169.5M | $30.2M |
| FY2017 | — | $225.3M | $20.2M |
| FY2018 | $29.9M | $215.1M | $57.0M |
| FY2019 | — | $69.9M | $34.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $92.5M | $9.9M |
| FY2016 | — | $169.5M | $30.2M |
| FY2017 | — | $225.3M | $20.2M |
| FY2018 | $29.9M | $215.1M | $57.0M |
| FY2019 | — | $69.9M | $34.2M |